Disease modifying therapies for multiple sclerosis: benefit and acceptability

Harrison, Joanna orcid iconORCID: 0000-0001-8963-7240, Hill, James Edward orcid iconORCID: 0000-0003-1430-6927 and Palmer, Karen (2022) Disease modifying therapies for multiple sclerosis: benefit and acceptability. British Journal of Neuroscience Nursing, 18 (Sup3). S16-S19. ISSN 2052-2800

[thumbnail of AAM]
Preview
PDF (AAM) - Accepted Version
Available under License Creative Commons Attribution.

320kB

Official URL: https://doi.org/10.12968/bjnn.2022.18.Sup3.S16

Abstract

Disease modifying therapies are available for the treatment of relapse remitting multiple sclerosis, making relapses less common and severe. A Cochrane systematic review was undertaken to compare their benefit and acceptability. This article summarises and appraises the review evidence.


Repository Staff Only: item control page